A miniaturized wearable device is able to measure chloride levels in sweat, the gold standard tool for diagnosing cystic…
Articles by Steve Bryson, PhD
Newborn screening (NBS) in Switzerland correctly identified 96% of cystic fibrosis (CF) cases over an 11-year period, a study…
After starting Trikafta, people with cystic fibrosis (CF) significantly reduced their use of other CF-related medications, suggesting that many…
Pulmonary ionocytes, a rare airway cell type that produces high levels of CFTR — the protein that’s defective in…
The European Commission (EC) has expanded the approval of Kalydeco (ivacaftor) for the treatment of infants with cystic…
A grant of $500,000 in Australian dollars (around $326,000) will support researchers there in the development of antibiotics formulated with…
Elevated levels of the pro-inflammatory signaling protein galectin-3 in the bloodstream of children with clinically stable cystic fibrosis (CF)…
A protein secreted into the airways, called SPLUNC1, may be a sensitive biomarker of both mild pulmonary exacerbations and treatment…
Children with cystic fibrosis (CF) who began taking Orkambi (lumacaftor/ivacaftor) between ages 2 and 5 showed improved height,…
Zinc may be key to reducing bacterial infections in people with cystic fibrosis (CF), researchers at the University of…